The Bulletin
Men's Weekly


.

Immuno Cure Successfully Admitted into the HKSTP Elite Programme

  • Written by The Bulletin

Remarkable funding support for becoming a biotech unicorn

HONG KONG SAR - Media OutReach Newswire - 26 June 2024 - Immuno Cure BioTech ("Immuno Cure") is delighted to announce its recent successful admission to the prestigious Elite Programme of Hong Kong Science & Technology Park ("HKSTP"), positioning the company for accelerated growth and innovation in the field of biotechnology in Hong Kong.

Read more: Immuno Cure Successfully Admitted into the HKSTP Elite Programme